note: immutep targeted combo patents expiring 2036 citing both keytruda and opdivo with efti...
also note: keytruda patent expires circa 2025/2026...
CHECKPOINT INHIBITORS - What The?, page-13
-
- There are more pages in this discussion • 18 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
28.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $407.2M | |||
| Open | High | Low | Value | Volume |
| 28.0¢ | 28.5¢ | 27.5¢ | $164.7K | 594.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 21 | 296832 | 27.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 28.0¢ | 116171 | 18 |
View Market Depth
| Last trade - 13.46pm 06/11/2024 (20 minute delay) ? |
| IMM (ASX) Chart |